Skip to main content
Fig. 3 | Pediatric Rheumatology

Fig. 3

From: Rapid and sustained response to JAK inhibition in a child with severe MDA5 + juvenile dermatomyositis

Fig. 3

Improvement in CMAS score and decrease of interferone score during treatment. Starting from initial diagnosis in september 2021, this picture reveals the constant improvement in the childhood myositis assessment scale (CMAS) as well as the constant decrease of interferone score in our patient. The different treatments of the patient are displayed in light grey. For detailed information about the measurement of the interferone score, please see the supplementary material

Back to article page

Pediatric Rheumatology

ISSN: 1546-0096